Emphasizing the role of monoamine oxidase (MAO) in the etiology and pathogenesis of Parkinson's disease and Alzheimer's disease, this up-to-date reference describes the genetics, physiology, biochemistry, pharmacology, and clinical aspects of this very important class of enzymes.
Details how the interaction between selegiline (deprenyl) and MAO may retard the progression of neurodegenerative disorders!
Providing the latest theories on how selegiline operates, Monoamine Oxidase Inhibitors in Neurological Diseases
presents fundamental information on MAO types A and B
examines the distribution of MAO A and B in the normal human brain
investigates the effects of disease and aging on MAO A and B
analyzes a critical role for MAO in the toxic action in Parkinson's disease
elucidates selegiline's novel ability to delay the progression or repair the damage of dopaminergic neurons
discusses the usefulness of MAO inhibitors in psychiatric disease
and more!
